Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (11-20 of 315) with videos related to

Pageof 32
Sort By:
Nature|November 16, 2012
Edward Donnall Thomas (1920-2012)Rainer Storb
Leukemia & Lymphoma|August 20, 2005
Graft-vs-host disease after non-myeloablative hematopoietic cell transplantationMarco Mielcarek, Rainer Storb
Leukemia & Lymphoma|January 3, 2013
Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and futureRon Ram, Rainer Storb
Immunologic Research|August 30, 2003
The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseasesMichael Maris, Rainer Storb
Cancer Treatment Reviews|August 21, 2003
Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignanciesMarco Mielcarek, Rainer Storb
Best Practice & Research. Clinical Haematology|September 26, 2006
The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspectiveFrédéric Baron, Rainer Storb
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Mesenchymal stromal cells: a new tool against graft-versus-host disease?Frédéric Baron, Rainer Storb
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioningFrédéric Baron, Rainer Storb
Current Opinion in Hematology|January 27, 2007
Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remissionFrédéric Baron, Rainer Storb
Current Opinion in Hematology|December 18, 2004
Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host diseaseLauri Burroughs, Rainer Storb
Pageof 32

Showing results (11-20 of 315) with videos related to

Sort By:
Pageof 32
Nature|November 16, 2012
Edward Donnall Thomas (1920-2012)Rainer Storb
Leukemia & Lymphoma|August 20, 2005
Graft-vs-host disease after non-myeloablative hematopoietic cell transplantationMarco Mielcarek, Rainer Storb
Leukemia & Lymphoma|January 3, 2013
Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and futureRon Ram, Rainer Storb
Immunologic Research|August 30, 2003
The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseasesMichael Maris, Rainer Storb
Cancer Treatment Reviews|August 21, 2003
Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignanciesMarco Mielcarek, Rainer Storb
Best Practice & Research. Clinical Haematology|September 26, 2006
The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspectiveFrédéric Baron, Rainer Storb
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Mesenchymal stromal cells: a new tool against graft-versus-host disease?Frédéric Baron, Rainer Storb
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioningFrédéric Baron, Rainer Storb
Current Opinion in Hematology|January 27, 2007
Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remissionFrédéric Baron, Rainer Storb
Current Opinion in Hematology|December 18, 2004
Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host diseaseLauri Burroughs, Rainer Storb
Pageof 32